Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

A film exploring the complexities of weight stigma, titled "Your Fat Friend," is set to be part of a national campaign for ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

The company posted an earnings per share (EPS) loss of $0.38, with total revenue reaching $113.9 million. Despite a slight uptick of 0.28% during regular trading hours, the stock fell 4.17% in ...

In this light, the stock's recent weakness may be a good opportunity to jump aboard. - Monotherapy weight loss with better impact on body composition than incretin therapies like tirzepatide and ...

Should you buy Viking Therapeutics stock before it goes to the moon ... checks out considering what could happen with approved weight loss drugs when you consider competitors and Holz's proposed ...

Wall Street's consensus price target of $110 implies more than 220% upside to Viking stock. Wall Street has ... what could happen with approved weight loss drugs when you consider competitors ...

The stock's analyst price targets range from $11 to $15, indicating potential upside from current levels. HomeStreet reported a larger-than-expected loss, with EPS missing forecasts by $0.04. Revenue ...

The stock's analyst price targets range from $11 to $15, indicating potential upside from current levels. HomeStreet reported a larger-than-expected loss, with EPS missing forecasts by $0.04.